Other OTC - Delayed Quote • USD
Alseres Pharmaceuticals, Inc. (ALSE)
At close: October 18 at 2:06 PM EDT
Breakdown
TTM
Total Revenue
473.7300
Gross Profit
473.7300
Operating Expense
1,317.5110
Operating Income
-843.7810
Net Non Operating Interest Income Expense
-237.7940
Other Income Expense
279.4090
Pretax Income
-776.6360
Net Income Common Stockholders
-776.6360
Diluted NI Available to Com Stockholders
-776.6360
Basic EPS
-100.00
Diluted EPS
-100.00
Basic Average Shares
6.1270
Diluted Average Shares
6.1270
Total Operating Income as Reported
-843.7810
Total Expenses
1,317.5110
Net Income from Continuing & Discontinued Operation
-776.6360
Normalized Income
-741.3840
Interest Expense
237.7940
Net Interest Income
-237.7940
EBIT
-538.8420
EBITDA
-538.8420
Net Income from Continuing Operation Net Minority Interest
-776.6360
Total Unusual Items Excluding Goodwill
-35.2520
Total Unusual Items
-35.2520
Normalized EBITDA
-503.5900
-
Yahoo Finance Plus Essential access required. Unlock Access